Cazar-Almache ME, Palacios-Vivar DE, Cañar-Rivera G, Abril-Cordero M, Espinoza-Soto PE

Language: Spanish
References: 18
Page: 150-154
PDF size: 237.87 Kb.

ABSTRACT

Introduction: Brown tumor is a rare pathology resulting from uncontrolled hyperparathyroidism, which produces areas of localized bone destruction. They are present at the facial level in the mandible and maxilla, ribs, clavicle, pelvic waist and upper and lower extremities. Its name is given by the pigmentation of the extravasation of blood and hemosiderin to the tumor. It can manifest itself in any decade of life. Has greater predisposition in women of the fourth and fifth decade of life. Its presence at the level of maxillary bones requires a complex system of studies and multidisciplinary management for diagnostic confirmation and treatment. Clinical case: The case of a 36 year old patient with no personal or family history is reported. She comes by referral for placement of a bone graft for dental mobility. In the image evaluation, there is a right radiolucent zone in the body of the mandible, in relation to the teeth. The lesion usually presents as a well-delimited unilateral or multilocular radiolucent area; another important radiographic finding in hyperparathyroidism is the absence of hard laminae around the dental organs. Conclusions: The brown tumor should be considered as a differential diagnosis of mandibular tumors due to the fact that not every tumor has a primary etiology.

REFERENCES

1. Peña-Torres LM, Soriano-Padilla F, Diaz-de-León L, Robles-Páramo A. Tumor pardo del hiperparatiroidismo en maxilar y mandíbula. Reporte de una caso. Rev ADM 2002; 59(2): 63-6.

2. Noriega-Jalil AB, Valverde-García YA, García-Barajas J, García-Hernández H, González-Torres JA, Ramos-Armengol DC, et al. Mandibular brown tumor as atypical presentation of primary hyperparathyroidism: two case reports and literature review. AACE Clinical Case Reports 2018; 4(3): e203-8. Available from: http://journals.aace.com/doi/10.4158/EP171967.CR

3. Gallana-Álvarez S, Salazar-Fernández CI, Avellá-Vecino FJ, Torres-Gómez J, Pérez-Sánchez JM. Tumor pardo maxilar: elemento diagnóstico de hiperparatiroidismo primario. Rev Esp Cirug Oral y Maxilofac 2005; 27(4): 225-30.

4. Chavin HC, Pisarevsky AA, Chavin C, Koll L, Petrucci EA. Tumor pardo como manifestación inicial de hiperparatiroidismo primario. Medicina (B Aires) 2008; 68: 219-21.

5. Verma K, Verma D, Patwardhan N, Verma P. Craniofacial brown tumor as a result of secondary hyperparathyroidism in chronic renal disease patient: a rare entity. J Oral Maxillofac Pathol [Internet] 2014; 18(2): 267. Available from: http://www.jomfp.in/text.asp?2014/18/2/267/140779

6. Can Ö, Boynueǧri B, Gökçe AM, Özdemir E, Ferhatoǧlu F, Canbakan M, et al. Brown tumors: a case report and review of the literature. Case Rep Nephrol Dial 2016; 6(1): 46-52.

7. Ftohy-Abdelrahman TE. Brown Jaw tumors: challenges and outcomes. Int Surg J 2017; 4(11): 3586-9.

8. Araya I, Yanine N, Cornejo M, Villanueva J. Tumor pardo maxilar refractario a tratamiento convencional. Rev Esp Cirug Oral y Maxilofac 2014; 36(1): 21-6. Available from: http://dx.doi.org/10.1016/j.maxilo.2012.01.005

9. Gómez-Oliveira G, García-Rozado González A, López-Cedrún JL. ¿Cuál es su diagnóstico ? Tumor de células gigantes mandibular. Rev Esp Cir Oral y Maxilofac [Internet] 2005; 6: 375-80. Disponible en: http://scielo.isciii.es/pdf/maxi/v27n6/residente1.pdf

10. Alemán‐Iñiguez JM, Mora‐Bravo F, Bravo‐Aguilar C. Rara localización de tumor pardo en insuficiencia renal crónica. Reporte de un caso pediátrico y actualización. Rev Port Endocrinol Diabetes e Metab [Internet] 2016; 11(2): 220-7. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1646343916300013

11. Fernández-Sanromán J, Antón-Badiola IM, Costas-López A. Tumor pardo en la sínfisis mandibular como primera manifestación clínica de hiperparatiroidismo: Diagnóstico y tratamiento. Med Oral Patol Oral Cir Bucal 2005; 10(2): 169-72.

12. Hussain M, Hammam M. Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report. J Med Case Rep [Internet] 2016; 10(1): 166. Available from: http://dx.doi.org/10.1186/s13256-016-0933-4

13. Arias W, Ayala A, Pacheco F, Barzallo D. Tumor pardo multifocal como manifestación paratiroideo asociado a carcinoma papilar de tiroides. Rev Chil Cir 2014; 66: 592-8.

14. Reséndiz-Colosia JA, Alvarado-Cabrero I, Flores-Díaz R, Hernández-San Juan M, Barroso-Bravo S, Gómez-Acosta F, et al. Múltiples tumores pardos maxilofaciales como manifestación de hiperparatiroidismo primario. Gac Med Mex 2008; 144(2): 155-60.

15. Herrera-Mujica R, Agurto-Huerta A, Diaz L, Gonzales H. Radiología digital en la evaluación de calcificaciones en tejidos blandos. Kiru 2012; 9(2): 161-6.

16. Sánchez R, Del Castillo J, Moran M, Pingarron M, Buergueño M. Queratoquiste odontogénico mandibular. Presentación como trismus de larga evolución. Rev Esp Cir Oral y Maxilofac 2008; 4: 291-4.

17. Sosa R, Umérez C, Maestu C. Queratoquiste odontogénico. Acta Odontológica Venezolana [Internet] 2002; 40(3). Disponible en: https://www.actaodontologica.com/ediciones/2002/3/queratoquiste_odontogenico.asp

18. Adeel M, Rajput MSA, Arain AA, Baloch M, Khan M. Ameloblastoma: management and outcome. Cureus 2018; 10(10): e3437.